Log in to save to my catalogue

Anti-Islet Autoantibodies in Type 1 Diabetes

Anti-Islet Autoantibodies in Type 1 Diabetes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10298549

Anti-Islet Autoantibodies in Type 1 Diabetes

About this item

Full title

Anti-Islet Autoantibodies in Type 1 Diabetes

Author / Creator

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2023-06, Vol.24 (12), p.10012

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Anti-islet autoantibodies serve as key markers in immune-mediated type 1 diabetes (T1D) and slowly progressive T1D (SPIDDM), also known as latent autoimmune diabetes in adults (LADA). Autoantibodies to insulin (IAA), glutamic acid decarboxylase (GADA), tyrosine phosphatase-like protein IA-2 (IA-2A), and zinc transporter 8 (ZnT8A) are currently empl...

Alternative Titles

Full title

Anti-Islet Autoantibodies in Type 1 Diabetes

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10298549

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10298549

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms241210012

How to access this item